6533b82cfe1ef96bd128feb6
RESEARCH PRODUCT
The role of panitumumab in combination with ECX in perioperative chemotherapy of unselected patients with locally advanced gastroesophageal adenocarcinomas: Randomized phase II study of the German Cancer Society.
Markus MoehlerStefan Paul MoenigThomas HoehlerMichael StahlAndré L. MihaljevicStephan KanzlerVolker KunzmannHansjochen WilkeAndreas SandermannAndrea TannapfelSebastian SchrollPeter C. Thuss-patienceFlorian LordickChristoph SchumacherHans-joachim Meyersubject
OncologyCancer Researchmedicine.medical_specialtybusiness.industryLocally advancedPhases of clinical researchImproved survivalCancermacromolecular substancesmedicine.diseaseSurgerycarbohydrates (lipids)stomatognathic diseasesOncologyInternal medicinePerioperative chemotherapyotorhinolaryngologic diseasesmedicinebacteriaPanitumumabAdenocarcinomabusinessmedicine.drugdescription
4040 Background: Perioperative chemotherapy (pCT) significantly improved survival of patients (pts) with locally advanced esophagogastric adenocarcinoma (la EGC). However, ~60% of pts will later di...
year | journal | country | edition | language |
---|---|---|---|---|
2015-05-20 | Journal of Clinical Oncology |